SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-024240
Filing Date
2019-05-07
Accepted
2019-05-07 16:16:26
Documents
4
Period of Report
2019-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv520883_8k.htm 8-K 31009
2 EXHIBIT 99.1 tv520883_ex99-1.htm EX-99.1 20500
3 GRAPHIC image_001.jpg GRAPHIC 4276
4 GRAPHIC image_002.jpg GRAPHIC 11259
  Complete submission text file 0001144204-19-024240.txt   74609
Mailing Address 2701 KENT AVENUE WEST LAFAYETTE IN 47906-1382
Business Address 2701 KENT AVE WEST LAFAYETT IN 47906-1382 3174634527
BIOANALYTICAL SYSTEMS INC (Filer) CIK: 0000720154 (see all company filings)

IRS No.: 351345024 | State of Incorp.: IN | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-23357 | Film No.: 19803331
SIC: 8731 Services-Commercial Physical & Biological Research